Saha, S. K. Et Al. 2019. Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer. Journal of Clinical Medicine , vol.8, no.3 .

Saha, S. K., Riazul Islam, S., Abdullah-Al-Wadud, M., Islam, S., Ali, F., & Park, K. S., (2019). Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer. Journal of Clinical Medicine , vol.8, no.3.

Saha, Subbroto Et Al. "Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer," Journal of Clinical Medicine , vol.8, no.3, 2019

Saha, Subbroto K. Et Al. "Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer." Journal of Clinical Medicine , vol.8, no.3, 2019

Saha, S. K. Et Al. (2019) . "Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer." Journal of Clinical Medicine , vol.8, no.3.

@article{article, author={Subbroto Kumar Saha Et Al. }, title={Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer}, journal={Journal of Clinical Medicine}, year=2019}